ANTX · AN2 Therapeutics, Inc.

NasdaqHealthcareBiotechnology

An2 Therapeutics Inc Is A Biopharmaceutical Company Focused On Discovering And Developing Novel Small Molecule Therapeutics Derived From Its Boron Chemistry Platform. The Company Has A Pipeline Of Boron-Based Compounds In Development For Chagas Disease, Non-Tuberculous Mycobacterial (Ntm) And Melioidosis, Along With Early-Stage Programs Focused On Targets In Infectious Diseases And Oncology. Product Candidate An2-502998 Epetraborole.

HealthcareNasdaqUSMid Float

FLOAT

28.8M

FREE FLOAT %

76%

SHARES O/S

37.7M

MARKET CAP

$134.0M

EXCHANGE

Nasdaq

COUNTRY

ANTX Catalyst History

No catalysts recorded for ANTX yet

Day Trader Sniper hasn't classified a publishable catalyst for ANTX yet. New events appear here as they're scored.

Be early on the next ANTX spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

ANTX · AN2 Therapeutics, Inc.

ANTX Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.